Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivo

Journal of Lipid Research

Volumn 55, Issue 6, 2014, Pages 1019-1032

  Varshney, Salil ^a   Shankar, Kripa ^a   Beg, Muheeb ^a   Balaramnavar, Vishal M ^b   Mishra, Sunil Kumar ^b   Jagdale, Pankaj ^c   Srivastava, Shishir ^b   Chhonker, Yashpal S ^b   Lakshmi, Vijai ^d   Chaudhari, Bhushan P ^c   Bhatta, Rabi Shankar ^b   Saxena, Anil Kumar ^b   Gaikwad, Anil Nilkanth ^a  

^a Head of Department Pharmacology   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^d KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

3T3 L1; C3H10T1 2; Dysoxylum binacteriferum Hook. f.; S phase arrest

Indexed keywords

ADIPOCYTE PROTEIN 2; ANTILIPEMIC AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; FAS ANTIGEN; GLUCOSE TRANSPORTER 4; LIPID; LIVER X RECEPTOR ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROHITUKINE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG; 5,7-DIHYDROXY-2-METHYL-8-(4-(3-HYDROXY-1-METHYL)-PIPERIDINYL)-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; PIPERIDINE DERIVATIVE;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE ARREST; CELL EXPANSION; CONTROLLED STUDY; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG ISOLATION; DRUG MECHANISM; DRUG PURITY; DYSLIPIDEMIA; DYSOXYLUM BINACTERIFERUM; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; S PHASE CELL CYCLE CHECKPOINT; SYRIAN HAMSTER; 3T3-L1 CELL LINE; ANIMAL; CHEMISTRY; DRUG EFFECTS; FEMALE; MALE; MESOCRICETUS; METABOLISM; MITOSIS; MOUSE; PATHOLOGY;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; CHROMONES; DYSLIPIDEMIAS; FEMALE; MALE; MESOCRICETUS; MICE; MITOSIS; PIPERIDINES; S PHASE CELL CYCLE CHECKPOINTS;

EID: 84901649734     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M039925     Document Type: Article

References (66)

1. Ginsberg, H. N., and P. R. MacCallum. 2009. The obesi ty, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J. Cardiometab. Syndr. 4: 113-119.
2. Adamczak, M., and A. Wiecek. 2013. The adipose tissue as an endocrine organ. Semin. Nephrol. 33: 2-13.
3. Taillan, B., J. G. Fuzibet, G. Garnier, A. Pesce, H. Vinti, M. C. Saint-Paul, and P. Dujardin. 1991. [Hepatic involvement in human immunodefi ciency virus infection. 104 histologically documented cases]. Ann. Med. Interne (Paris). 142: 226-227. French.
4. Zhang, M., K. Ikeda, J. W. Xu, Y. Yamori, X. M. Gao, and B. L. Zhang. 2009. Genistein suppresses adipogenesis of 3T3-L1 cells via multiple signal pathways. Phytother. Res. 23: 713-718.
5. Noto, A., P. Zahradka, N. Yurkova, X. Xie, H. Truong, E. Nitschmann, M. R. Ogborn, and C. G. Taylor. 2007. Dietary conjugated linoleic acid decreases adipocyte size and favorably modifi es adipokine status and insulin s ensitivity in obese, insulin-resistant rats. Metabolism. 56: 1601-1611.
6. Kim, H. K., M. Della-Fera, J. Lin, and C. A. Baile. 2006. Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J. Nutr. 136: 2965-2969.
7. Kim, H., and K. Sakamoto. 2012. (-)-Epigallocatechin gallate suppresses adipocyte differentiation through the MEK/ERK and PI3K/Akt pathways. Cell Biol. Int. 36: 147-153.
8. Yang, J. Y., M. A. Della-Fera, S. Rayalam, S. Ambati, D. L. Hartzell, H. J. Park, and C. A. Baile. 2008. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci. 82: 1032-1039.
9. Rayalam, S., J. Y. Yang, S. Ambati, M. A. Della-Fera, and C. A. Baile. 2008. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother. Res. 22: 1367-1371.
10. Ambati, S., J. Y. Yang, S. Rayalam, H. J. Park, M. A. Della-Fera, and C. A. Baile. 2009. Ajoene exerts potent effects in 3T3-L1 adipocytes by inhibiting adipogenesis and inducing apoptosis. Phytother. Res. 23: 513-518.
11. Ray alam, S., M. A. Della-Fera, and C. A. Baile. 2008. Phytochemicals and regulation of the adipocyte life cycle. J. Nutr. Biochem. 19: 717-726.
12. Klebe, G., and U. Abraham. 1999. Comparative m olecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries. J. Comput. Aided Mol. Des. 13: 1-10.
13. Klebe, G., U. Abraham, and T. Mietzner. 1994. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 37: 4130-4146.
14. Catalyst Version 4.1 ed. 2006. Accelrys Inc., San Diego, CA.
15. Jain, S. K., S. B. Bharate, and R. A. Vishwakarma. 2012. Cyclindependent kinase inhibition by fl avoalkaloids. Mini Rev. Med. Chem. 12: 632-649.
16. Singh, N., P. Singh, S. Shrivastva, S. K. Mishra, V. Lakshmi, R. Sharma, and G. Palit. 2012. Gastroprotective effect of anti-cancer compound rohitukine: possible role of gastrin antagonism and H(+) K (+)-ATP ase inhibition. Naunyn Schmiedebergs Arch. Pharmacol. 385: 277-286.
17. Mohana Kumara, P., S. Zuehlke, V. Priti, B. T. Ramesha, S. Shweta, G. Ravikanth, R. Vasudeva, T. R. Santhoshkumar, M. Spiteller, and R. Uma Shaanker. 2012. Fusarium proliferatum, an endophytic fungus from Dysoxylum binectariferum Hook.f, produces rohitukine, a chromane alkaloid possessing anti-cancer activity. Antonie van Leeuwenhoek. 101: 323-329.
18. Keshri, G., R. M. Oberoi, V. Lakshmi, K. Pandey, and M. M. Singh. 2007. Contraceptive and hormonal properties of the stem bark of Dysoxylum binectariferum in rat and docking analysis of rohitukine, the alk aloid isolated from active chloroform soluble fraction. Contraception. 76: 400-407.
19. Lakshmi, V., K. Pandey, A. Kapil, N. Singh, M. Samant, and A. Dube. 2007. In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani. Phytomedicine. 14: 36-42.
20. Arguello, F., M. Alexander, J. A. Sterry, G. Tudor, E. M. Smith, N. T. Kalavar, J. F. Greene, Jr., W. Koss, C. D. Morgan, S. F. Stinson, et al. 1998. Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymph oma xenografts. Blood. 91: 2482-2490.
21. Du, G. J., Z. Zhang, X. D. Wen, C. Yu, T. Calway, C. S. Yuan, and C. Z. Wang. 2012. Epigallocatechin gallate (EGCG) is the most effective can cer chemopreventive polyphenol in green tea. Nutrients. 4: 1679-1691.
22. Hö rmann, V., J. Kumi-Diaka, M. Durity, and A. Rathinavelu. 2012. Anticancer activities of genistein-topotecan combination in prostate cancer cells. J. Cell. Mol. Med. 16: 2631-2636.
23. Kang, J. W., J. H. Kim, K. Song, S. H. Kim, J. H. Yoon, and K. S. Kim. 2010. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother. Res. 24: S77-S82.
24. Vucenik, I ., and J. P. Stains. 2012. Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann. N. Y. Acad. Sci. 1271: 37-43.
25. Aballay, L. R., A. R. Eynard, P. Diaz Mdel, A. Navarro, and S. E. Munoz. 2013. Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutr. Rev. 71: 168-179.
26. Ito, K., R. Ishigamori, M. Mutoh, T. Ohta, T. Imai, and M. Takahashi. 2013. The A allele promotes azoxymethane-induced colorectal carcinogenesis via macrophage migration in hyperlipidemic/diabetic KK mice. Cancer Sci. 104: 835-843.
27. Hsu, C. L., and G. C. Yen. 2007. Effects of fl avonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. J. Agric. Food Chem. 55: 8404-8410.
28. Brooks, R. B., R. E. Br uccoleri, B. D. Olafson, D. J. States, S. Swaminathan, and M. Karplus. 1983. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4: 187-217.
29. Smellie, A., S. L. Teig, and P. Towbin. 1995. Poling: promoting conformational variation. J. Comput. Chem. 16: 171-187.
30. Wu, Z., E. D. Rosen, R. Brun, S. Hauser, G. Adelmant, A. E. Troy, C. McKeon, G. J. Darlington, and B. M. Spiegelman. 1999. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell. 3: 151-158.
31. Rosen, E. D., C. H. Hsu, X. Wang, S. Sakai, M. W. Freeman, F. J. Gonzalez, and B. M. Spiegelman. 2002. C/EBPalpha induces adipogenesis through PPARgamma: a unifi ed pathway. Genes Dev. 16: 22-26.
32. Hu, Y., and G. E. Davies. 2009. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation. Phytomedicine. 16: 864-873.
33. Horikawa, T., T . Shimada, Y. Okabe, K. Kinoshita, K. Koyama, K. Miyamoto, K. Ichinose, K. Takahashi, and M. Aburada. 2012. Polymethoxyfl avonoids from Kaempferia parvifl ora induce adipogenesis on 3T3-L1 preadipocytes by regulating transc ription factors at an early stage of differentiation. Biol. Pharm. Bull. 35: 686-692.
34. Bennett, C. N., S. E. Ross, K. A. Longo, L. Bajnok, N. Hemati, K. W. Johnson, S. D. Harrison, and O. A. MacDougald. 2002. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277: 30998-31004.
35. Avruch, J. 1998. Insulin signal transduction through protein kinase cascades. Mol. Cell. Biochem. 182: 31-48.
36. Morgan, T. M., T. D. Koreckij, and E. Corey. 2009. Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. Curr. Cancer Drug Targets. 9: 237-249.
37. Wu, K., C. Wang, M. D Amico, R. J. Lee, C. Albanese, R. G. Pestell, and S. Mani. 2002. Flavopiridol and trastuzumab synergistically inhibit proliferation of brea st cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways. Mol. Cancer Ther. 1: 695-706.
38. Zhang H.H.,J. Huang.K. Duvel.B. Boback,S. Wu,R.M. Squillace,C.L. Wu,B.D. Manning, 2009. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS ONE., 4, e6189.
39. Takahashi, S., M. Tamai, S. Nakajima, H. Kato, H. Johno, T. Nakamura, and M. Kitamura. 2012. Blockade of adipocyte differentiation by cordycepin. Br. J. Pharmacol. 167: 561-575.
40. Wei, Z., M. M. Seldin, N. Natarajan, D. C. Djemal, J. M. Peterson, and G. W. Wong. 2013. C1q/TNF-related protein 11 (CTRP11), a novel adipose stroma-derived regulator of adipogenesis. J. Biol. Chem. 288: 10214-10229.
41. Choi, K. M., Y. S. Lee, D. M. Sin, S. Lee, M. K. Lee, Y. M. Lee, J. T. Hong, Y. P. Yun, and H. S. Yoo. 2012. Sulforaphane inhibits mitotic clonal expansion during adipog enesis through cell cycle arrest. Obesity (Silver Spring). 20: 1365-1371.
42. Kwon, J. Y., S. G. Seo, S. Yue, J. X. Cheng, K. W. Lee, and K. H. Kim. 2012. An inhibitory effect of resveratrol in the mitotic clonal expansion and insulin signaling pathway in the early phase of adipogenesis. Nutr. Res. 32: 607-616.
43. Kwon, J. Y., S. G. Seo, Y. S. Heo, S. Yue, J. X. Cheng, K. W. Lee, and K. H. Kim. 2012. Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation. J. Biol. Chem. 287: 115 66-11578.
44. Tidhar, Y., H. Weissman, S. G. Wolf, A. Gulino, and B. Rybtchinski. 2011. Pathway-dependent self-assembly of perylene diimide/peptide conjugates in aqueous medium. Chemistry. 17: 6068-6075.
45. Yun, H. J., J. H. Kim, H. Y. Jeong, H. H. Ji, S. W. Nam, E. W. Lee, B. W. Kim, and H. J. Kwon. 2012. Widdrol blocks 3T3-L1 preadipocytes growth and differentiation due to inhibition of mit otic clonal expansion. J. Microbiol. Biotechnol. 22: 806-813.
46. Kim, C. Y., T. T. Le, C. Chen, J. X. Cheng, and K. H. Kim. 2011. Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. J. Nutr. Biochem. 22: 910-920.
47. Hsu, C. L., Y. J. Lin, C. T. Ho, and G. C. Yen. 2012. Inhibitory effects of garcinol and pterostilbene on cell proliferation and adipogenesis in 3T3-L1 cells. Food Funct. 3: 49-57.
48. Kalgaonkar, S., H. B. Gross, W. Yokoyama, and C. L. Keen. 2010. Effects of a fl avonol-rich diet on select cardiovascular parameters in a Golden Syrian hamster model. J. Med. Food. 13: 108-115.
49. Kurowska, E. M., and J. A. Manthey. 2004. Hypolipidemic effects and absorption of citrus polymethoxylated fl avones in hamsters with diet-induced hypercholesterolemia. J. Agric. Food Chem. 52: 2879-2886.
50. Auger, C., P. L. Teissedre, P. Gerain, N. Lequeux, A. Bornet, S. Serisier, P. Besancon, B. Caporiccio, J. P. Cristol, and J. M. Rouanet. 2005. Dietary wine phenolics catechin, quercetin, and resveratrol effi ciently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J. Agric. Food Chem. 53: 2015-2021.
51. Rima ndo, A. M., R. Nagmani, D. R. Feller, and W. Yokoyama. 2005. Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J. Agric. Food Chem. 53: 3403-3407.
52. Peng, C. H., L. K. Liu, C. M. Chuang, C. C. Chyau, C. N. Huang, and C. J. Wang. 2011. Mulberry water extracts possess an anti-obesity effect and ability to inhibit hepatic lipogenesis and promote lipolysis. J. Agric. Food Chem. 59: 2663-2671.
53. Huang, C., Y. Zhang, Z. Gong, X. Sheng, Z. Li, W. Zhang, and Y. Qin. 2006. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem. Biophys. Res. Commun. 348: 571-578.
54. Kim, M. H., J. S. Park, M. S. Seo, J. W. Jung, Y. S. Lee, and K. S. Kang. 2010 . Genistein and daidzein repress adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via Wnt/beta-catenin signalling or lipolysis. Cell Prolif. 43: 594-605.
55. Jang, E. M., M. S. Choi, U. J. Jung, M. J. Kim, H. J. Kim, S. M. Jeon, S. K. Shin, C. N. Seong, and M. K. Lee. 2008. Benefi cial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism. 57: 1 576-1583.
56. Guo, P., Q. Kai, J. Gao, Z. Q. Lian, C. M. Wu, C. A. Wu, and H. B. Zhu. 2010. Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase. J. Pharmacol. Sci. 113: 395-403.
57. Kong, W., J. Wei, P. Abidi, M. Lin, S. Inaba, C. Li, Y. Wang, Z. Wang, S. Si, H. Pan, et al. 2004. Berberine is a novel cholest erol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10: 1344-1351.
58. Song, T., S. O. Lee, P. A. Murphy, and S. Hendrich. 2003. Soy protein with or without isofl av ones, soy germ and soy germ extract, and daidzein lessen plasma cholesterol levels in golden Syrian hamsters. Exp. Biol. Med. (Maywood). 228: 1063-1068.
59. Zhang, Z., H. Wang, R. Jiao, C. Peng, Y. M. Wong, V. S. Yeung, Y. Huang, and Z. Y. Chen. 2009. Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol. Nutr. Food Res. 53: 921-930.
60. Nuclear Receptor Nomenclature Committee, 1999. A unifi ed nomenclature system for the nuclear receptor superfamily. Cell., 97, 161-163.
61. Chawla, A., J. J. Repa, R. M. Evans, and D. J. Mangelsdorf. 2001. Nuclear receptors and lipid physiology: opening the X-fi les. Science. 294: 1866-1870.
62. Briand, F., M. Treguier, A. Andre, D. Grillot, M. Issandou, K. Ouguerram, and T. Sulpice. 2010. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model. J. Lipid Res. 51: 763-770.
63. Mukherjee, R., K. T. Locke, B. Miao, D. Meyers, H. Monshizadegan, R. Zhang, D. Search, D. Grimm, M. Flynn, K. M. O Malley, et al. 2008. Novel peroxisome proliferator-activated receptor alpha agonists lower low-density lipoprotein and triglycerides, rai se high-density lipoprotein, and synergistically increase cholesterol excretion with a liver X receptor agonist. J. Pharmacol. Exp. Ther. 327: 716-726.
64. Kö nig, B., A. Koch, J. Spielmann, C. Hilgenfeld, G. I. Stangl, and K. Eder. 2007. Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. Biochem. Pharmacol. 73: 574- 585.
65. Van Rooyen, D. M., and G. C. Farrell. 2011. SREBP-2: a link between insulin resistance, hepatic cholesterol, and infl ammation in NASH. J. Gastroenterol. Hepatol. 26: 789-792.
66. Guo, Q., P. R. Wang, D. P. Milot, M. C. Ippolito, M. Hernandez, C. A. Burton, S. D. Wright, and Y. Chao. 2001. Regulation of lipid metabolism and gene expression by fenofi brate in hamsters. Biochim. Biophys. Acta. 1533: 220-232.